📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression. (2017)

First Author: Shah V

Attributed to: King's Health Partners Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13058-016-0789-y

PubMed Identifier: 28095868

Publication URI: http://europepmc.org/abstract/MED/28095868

Type: Journal Article/Review

Volume: 19

Parent Publication: Breast cancer research : BCR

Issue: 1

ISSN: 1465-5411